Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review
Sara H. Al-Hadidi, Hashim Alhussain, Hamad Abdel Hadi, et al.
Microbial Drug Resistance (2021) Vol. 27, Iss. 12, pp. 1705-1725
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis
Bradley J. Langford, Miranda So, Marina Simeonova, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 3, pp. e179-e191
Open Access | Times Cited: 106
WHO Critical Priority Escherichia coli as One Health Challenge for a Post-Pandemic Scenario: Genomic Surveillance and Analysis of Current Trends in Brazil
Bruna Fuga, Fábio P. Sellera, Louise Cerdeira, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 62
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Zikria Saleem, Brian Godman, Aislinn Cook, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 56
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic
Maria Mazzitelli, Darío Gregori, Lolita Sasset, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 984-984
Open Access | Times Cited: 26
Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis
Kasim Allel, Anne Peters, José Daniel Conejeros, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_1, pp. S20-S28
Open Access | Times Cited: 21
Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017–2023: opportunities and gaps
Michela Sabbatucci, Diane Ashiru‐Oredope, Laura Barbier, et al.
Pharmacological Research (2024) Vol. 204, pp. 107188-107188
Open Access | Times Cited: 9
Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review
Lubna I. Abu-Rub, Hana A. Abdelrahman, Al-Reem A. Johar, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 935-935
Open Access | Times Cited: 37
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2802-2822
Open Access | Times Cited: 24
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19?
Francesca Serapide, Angela Quirino, Vincenzo Scaglione, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 957-957
Open Access | Times Cited: 20
Determinants of the Empiric Use of Antibiotics by General Practitioners in South Africa: Observational, Analytic, Cross-Sectional Study
Sinenhlanhla Guma, Brian Godman, Stephen Campbell, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1423-1423
Open Access | Times Cited: 20
Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection
Emily R. Ko, Ricardo Henao, Katherine Frankey, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e227299-e227299
Open Access | Times Cited: 19
Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications
Zikria Saleem, Abdul Haseeb, Brian Godman, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 70-70
Open Access | Times Cited: 17
Antibiotic (Mis)Use in COVID-19 Patients before and after Admission to a Tertiary Hospital in Serbia
Aleksa Despotović, Aleksandra Barać, Teodora Cucanić, et al.
Antibiotics (2022) Vol. 11, Iss. 7, pp. 847-847
Open Access | Times Cited: 16
Overprescription of antibiotics for treating hospitalized COVID-19 patients: A systematic review & meta-analysis
Fazle Rabbi, Laura Banfield, Mehnaz Munir, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20563-e20563
Open Access | Times Cited: 9
SHEA statement on antibiotic stewardship in hospitals during public health emergencies
Tamar F. Barlam, Mayar Al Mohajer, Jaffar A. Al‐Tawfiq, et al.
Infection Control and Hospital Epidemiology (2022) Vol. 43, Iss. 11, pp. 1541-1552
Open Access | Times Cited: 15
Knowledge, Attitude and Practices of Self-Medication Including Antibiotics among Health Care Professionals during the COVID-19 Pandemic in Pakistan: Findings and Implications
Zia Ul Mustafa, Shahid Iqbal, Hafiz Rahil Asif, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 481-481
Open Access | Times Cited: 7
Endemic High-Risk Clone ST277 Is Related to the Spread of SPM-1-Producing Pseudomonas aeruginosa during the COVID-19 Pandemic Period in Northern Brazil
Pabllo Antonny Silva dos Santos, Yan Corrêa Rodrigues, Davi Josué Marcon, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2069-2069
Open Access | Times Cited: 7
Antimicrobial Resistance in Patients with COVID-19: A Systematic Review and Meta-Analysis
Bradley J. Langford, Miranda So, Marina Simeonova, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 11
A Retrospective Assessment of Laboratory Findings and Cytokine Markers in Severe SARS-CoV-2 Infection among Patients of Roma Population
Alexandra Herlo, Voichița Elena Lăzureanu, Adelina Raluca Marinescu, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6777-6777
Open Access | Times Cited: 11
Antimicrobial Stewardship (AMS) During COVID-19: Eyes and Ears on the AMS Team
Bethany Van Dort, Jonathan Penm, Angus Ritchie, et al.
Studies in health technology and informatics (2023)
Open Access | Times Cited: 5
Development of green micellar HPLC–DAD method for simultaneous determination of some sulbactam combinations used in COVID-19 regimen
Gamal H. Ragab, Hanaa Saleh, Nermeen M. Abdulla, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Rising incidence of carbapenem resistant isolates: an Argentinian hospital’s experience. More trouble in the aftermath of the COVID-19 pandemic
Maximiliano Gabriel Castro, Lucía Ubiergo, Macarena Vicino, et al.
Iberoamerican Journal of Medicine (2022) Vol. 4, Iss. 2, pp. 92-99
Open Access | Times Cited: 9
The effect of the COVID-19 pandemic on the incidence and resistance of Gram-negative bacilli and antimicrobial consumption in the intensive care units of a referral hospital in Buenos Aires
Gabriel Levy Hara, Ariel Antik, Sofia Iriarte Aguirre, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 2, pp. 107203-107203
Closed Access | Times Cited: 1
How did the COVID-19 pandemic affect antibiotic consumption within humanitarian emergencies? Results from five humanitarian contexts
Tuba Yavuz, Kate Clezy, Kristina Skender, et al.
Infection Prevention in Practice (2024) Vol. 6, Iss. 3, pp. 100385-100385
Open Access | Times Cited: 1
Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance
Emily R. Ko, Megan E. Reller, L. Gayani Tillekeratne, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top